[KYMR] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[KYMR] Kymera Therapeutics, Inc.
Announcement Date
23-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 20.82%
YoY- -0.43%
Quarter Report
KYMR's Result
KYMR's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 4,728 16,513 9,466 16,139 9,551 11,514 9,622 -37.70%
PBT -52,867 -38,799 -40,928 -34,865 -43,002 -40,257 -36,684 27.55%
Tax -895 4,632 -4,343 -818 1,916 -553 -249 134.46%
NP -52,867 -38,799 -36,585 -34,047 -43,002 -39,704 -36,435 28.13%
Tax Rate - - - - - - - -
Total Cost 57,595 55,312 46,051 50,186 52,553 51,218 46,057 16.05%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -1,118.17 -234.96 -386.49 -210.96 -450.24 -344.83 -378.66 105.69%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.90 -0.67 -0.63 -0.59 -0.79 -0.77 -0.71 17.10%
EPS Diluted -0.90 -0.67 -0.63 -0.59 -0.79 -0.77 -0.71 17.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.